NVST

Envista Holdings Corporation

$25.84

-0.50%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands.

Source: Yahoo Finance
AI summary

Price & performance

1M+6.9%
3M-12.8%
YTD+15.1%
1Y+23.9%
52-week range—
Beta1.24
Full chart and returns against a benchmark

Q-Score

71/ 100

Quality against peers; 50 is the peer median.

Growth53
Risk67
Performance47
Valuation86
Profitability77
Leverage49
Sentiment65
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.7B+8.3%
Net income$47M
Net margin1.7%+46.3 pts
Historical fundamentals

Revenue exposure

53%of revenue from outside the US
North America51%
Western Europe23%
High-Growth Markets22%
Regions, segments, customers and suppliers

Valuation

NVSTIndustryP/E6.5449.36P/S1.443.73EV/EBITDA5.2423.12P/B1.343.92PEG0.000.00
Dividend yield0.00%
Every valuation metric

Earnings

Feb 3next report
EPS estimate$0.36
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate